Podcasts about cme

Michael Hein, MS, MD, MHCM, Associate Certified Coach (ACC), believes that when healthcare leaders don't fully understand complexity, it leads to burnout, turnover, and poor patient care—issues he considers preventable forms of human suffering. Healthcare is more complex than ever, and traditional top-down methods often exacerbate these challenges. Success today requires leaders who adapt, absorb uncertainty, and react quickly. For many, this means embracing new leadership mindsets. With over thirty years of experience in healthcare, Michael is Senior Vice President and an executive coach at MEDI Leadership, the top healthcare coaching firm in the US. Drawing from clinical and executive roles, he helps leaders make the mindset shifts needed for success in complexity.Previously, Michael was CEO of a nonmerger hospital network and Chief Medical Officer at Catholic Health Initiatives. He led transformations at the Veterans Health Administration and cofounded KPI Ninja, a healthcare data company.Michael holds degrees from the University of South Dakota, Harvard's T.H. Chan School of Public Health, and St. Cloud State University. He is a certified executive coach through the International Coaching Federation, trained at the Hudson Institute of Coaching. His experience bridges frontline care and strategic leadership, coaching leaders to drive sustainable change in complex organizations.His book, Shifting Toward Unorthodoxy: Ten Unconventional Mindsets that Help Healthcare Leaders Succeed in a Complex World, encourages a shift from outdated leadership mindsets to adaptive ones. A lifelong athlete, Michael enjoys cycling and swimming.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

“Probably the most exciting thing I've seen in gene therapy over the last ten years is we now have a lot of tools for selective delivery, which will hopefully make treatments more safe and a lot more successful,” says Dr. Jessica Duis, a geneticist and pediatrician focused on the management of individuals with complex, rare disorders. Dr. Duis, who has worked on several gene therapies that are now approved or progressing through the accelerated approval pathway, is currently VP of Clinical Development at GondolaBio, a clinical-stage biopharmaceutical company focused on developing therapeutics for genetic diseases. As you'll learn in this Year of the Zebra episode with host Lindsey Smith, Dr. Duis is encouraged by other recent advances in genetic technology as well, and thinks momentum will grow as breakthrough treatments emerge. “I think we're hopefully going to continue to see companies that are working in rare disease be more successful and really drive how regulators think about making decisions in terms of bringing treatments to patients. I think we're at the tip of the iceberg in terms of the future of truly transformational therapies.”  This wide ranging conversation also explores Dr. Duis' team approach to patient care, her work on clinical endpoints, the importance of patient communities, and her book series, Rare Siblings Stories.Mentioned in this episode:GondolaBioRareDiseaseDocElsevier Healthcare Hub on Rare DiseasesRare Sibling Stories If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Drs. Marc Toeteberg-Harms and Soshian Sarrafpour join host Dr. Andrew Pouw to discuss micropulse transscleral laser therapy for glaucoma, a less invasive procedure compared with traditional continuous-wave cyclophotocoagulation. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Bitcoin rose to $120,000 for the first time since setting a record high seven weeks ago as speculation increases that the US government shutdown will drive investors to safe-haven assets.~This episode is sponsored by iTrust Capital~iTrustCapital | Get $100 Funding Reward + No Monthly Fees when you sign up using our custom link! ➜ https://bit.ly/iTrustPaul00:00 Intro00:10 Sponsor: iTrust Capital01:00 Day 201:30 Republican no show01:55 New quarter, same story03:15 Bitcoin chart04:00 Job impact past Oct. 1706:15 Shutdown may last long, but it doesn't matter07:30 Fed cuts will fuel irrational exuberance09:45 Bitcoin breakout12:00 Strongest market in modern history13:10 Silver rally14:00 ETHtober?15:55 CME group 24/7 trading16:25 SWIFT17:00 Charts19:30 Outro#Crypto #Bitcoin #Ethereum~Bitcoin Surges on Government Shutdown

The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits.On this episode we have the creative Dr. Leah Brancheck :Board certified neurologist in St. Louis, MOAuthor: RabRab and the Big Angry Feelings She shares:Personal journey of stress as a medical student and parentFlexing her emotional muscleLove for writing and drawingLearning and growing with her childrenQuest to raise emotionally healthy childrenAge appropriate guide to manage the big feelings in childrenInformation for Dr. BrancheckBook WebsiteLinkedInInformation for Dr. Robyn Tiger & StressFreeMD:Check out StressFreeMD & CME offerings Get the book: Feeling Stressed Is OptionalGet your 4 FREE stress relieving videosPhysicians: join our free private physicians-only Facebook groupRetreats REVIVE! Lifestyle Medicine Well-Being Group CoachingPrograms on Demand Private 1:1 Coaching Schedule your FREE 30-Minute Stress Relief Strategy CallFollow me on Social Media: InstagramLinkedInFacebookTwitterPodcast websitePlease rate & Review the Show!Contactinfo@stressfreemd.net 

How do you take one complex medical concept and make it clear, accurate, and actionable for both clinicians and patients, without losing credibility?If you're a CME writer, you know the challenge of translating science into education that actually sticks. But as more CME projects tether clinician education with patient-facing components, the real test is flexing your craft to serve two very different audiences at once. Get this right, and you not only improve learning, you expand your professional scope and impact.In this episode, you'll discover:How to apply practical frameworks to dual-audience writing.Structural techniques that make content engaging, empathetic, and accessible.A simple 3-sentence exercise to sharpen clarity for patients and precision for clinicians—anytime, anywhere.

BUFFALO, NY - October 1, 2025 – Oncotarget is proud to announce that its Editor-in-Chief, Wafik S. El-Deiry, MD, PhD, FACP, will chair the WIN Symposium as the Oncology Track of the Advancing Precision Medicine (APM) Annual Conference held October 3–4, 2025, at the Pennsylvania Convention Center in Philadelphia. The WIN Consortium annual symposium featured as the Oncology Track of the APM Annual Conference 2025 unites global leaders in oncology, translational science, and precision medicine. This year's program features keynote lectures, multi-track sessions– WIN Symposium, Multi-Omics Integration and Precision Medicine Outside of Oncology– and networking opportunities designed to accelerate the translation of research into clinical practice. Highlights include: --A keynote at opening of the WIN Symposium in Philadelphia by William G. Kaelin, Jr., MD — 2019 Nobel Laureate. --Other luminaries in Oncology are speaking, including AACR President Lillian Siu, MD and AACR President-Elect Keith Flaherty, MD along with internationally recognized leaders in precision oncology. --A world-class precision oncology molecular tumor board and oral presentations from the most competitive abstracts are part of the program. --Multi-omics and disease-specific tracks spanning oncology, neurology, cardiovascular disease, rare disease, and infectious disease. --Opportunities for collaboration among scientists, clinicians, industry innovators, and policymakers. Registration is still open. Attendance is free for students, academic/government/non-profit participants, healthcare providers, and investors. The event provides CME credits. For full program details, visit the APM Annual Conference website. About WIN Consortium: WIN Consortium is a non-profit association headquartered in France. WIN was the first consortium that assembled all stakeholders of cancer care, from academia, industry, and patient advocates to work together across the globe. The WIN network assembles 34 world-class academic medical centers, industries, research organizations and patient advocates spanning 18 countries and 5 continents, aligned to launch trials to bolster Precision Oncology across the world. It was also the first organization to launch a N-of-One study using transcriptomics in addition to genomics to inform therapeutic choice in the WINTHER study. WIN is the organizer of the WIN symposia in Precision Oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh

Ready to turn procrastination into productivity and make to-do lists work for you? Dr. Bradley Block and Dr. Russell Ramsay continue their discussion on time management for physicians. In part two, Dr. Ramsay explores forgiving procrastination through normalization, identifying progressivity (productive avoidance), and breaking tasks into small, actionable steps. He shares tips on using daily planners, keeping to-do lists manageable (2-5 items), and incorporating self-compassion to sustain motivation. While rooted in ADHD strategies, these insights help anyone in high-demand fields like medicine avoid overcommitment and build momentum. Tune in for practical advice on planners, task breakdown, and iterating for success—perfect for shifting work-life balance.Three Actionable Takeaway:Forgive and Normalize Procrastination – Recognize that relapse is 100%, and focus on understanding why it happens (e.g., lack of planning or overcommitment). Dr. Ramsay advises reframing through normalization and self-compassion: acknowledge slip-ups, identify specific causes, and get back on track without self-judgment to minimize future occurrences.Avoid Progressivity with Task Prioritization – Identify when you're doing lower-priority tasks (e.g., organizing files instead of charting) as avoidance. Dr. Ramsay suggests making priority tasks more appealing by focusing on hands-on starts, clear endpoints, and small steps—like mowing the lawn before taxes—to build momentum and prevent productive procrastination.Optimize To-Do Lists and Planners – Keep lists short (2-5 bite-sized items) and specific (e.g., "run errand" vs. vague goals). Dr. Ramsay recommends using planners for time-blocking, sequencing tasks logically, and iterating if needed; if a task lingers, break it down further into initial steps like "get to workstation" for sustained progress.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Russell Ramsay is a psychologist specializing in the assessment and psychosocial treatment of adult ADHD. With international lectures and over six books, including CBT for Adult ADHD and The Adult ADHD Toolkit, he advises on behavioral strategies for efficiency and well-being. Formerly at the University of Pennsylvania Perelman School of Medicine, he focuses on helping professionals, including physicians, manage procrastination and perfectionism. LinkedIn: https://www.linkedin.com/in/russell-ramsay-a8bbb310Website: https://www.cbt4adhd.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textWhat's the real cost of not growing your practice when the time is right? Spoiler alert: it's more than just lost revenue.Welcome to Medical Money Matters. Today's episode tackles something many practice leaders know they should think about—but often push to the bottom of the to-do list: when and how to scale your medical practice.Now, if you're a physician or practice administrator, your day is already full. You're seeing patients, solving staffing problems, reviewing financial reports, answering portal messages—and probably skipping lunch to do it. So when the topic of expansion comes up, it can feel overwhelming. Unnecessary. Even reckless.But here's the truth: in many cases, not growing when your practice needs to can be more damaging than growing too soon. And the impact goes beyond your bottom line. We're talking about team burnout, patient dissatisfaction, and even harm to your practice's reputation.The good news? There's a path to healthy, responsible growth. One that doesn't require overextending yourself or guessing your way through the process. That's what we're unpacking today.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Find it here: https://healtheps.com/physicians-edge-mastering-business-finance-in-your-medical-practice/  Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

Pediatrician Dr. Paul Bunch consults Dr. Nelson Rosen from the Division of Pediatric Surgery on pilonidal cysts. Episode recorded on July 30, 2025.  Resources discussed in this episode: Community Practice Support Tool  We are proud to offer CME and MOC Part 2 from Cincinnati Children's.  Credit is free and registration is required.  Please click here to claim CME credit via the post-test under "Launch Activity." Financial Disclosure:  The following relevant financial relationships have been disclosed: None All relevant financial relationships listed have been mitigated. Remaining persons in control of content have no relevant financial relationships. To Claim Credit: Click "Launch Activity." Click "Launch Website" to access and listen to the podcast. After listening to the entire podcast, click "Post Test" and complete.   Accreditation In support of improving patient care, Cincinnati Children's Hospital Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Specific accreditation information will be provided for each activity. Physician:  Cincinnati Children's designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  Nursing:  This activity is approved for a maximum 0.75 continuing nursing education (CNE) contact hours. ABP MOCpt2: Completion of this CME activity, which includes learner assessment and feedback, enables the learner to earn up to 0.75 points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. Cincinnati Children's submits MOC/CC credit for board diplomates. Credits AMA PRA Category 1 Credits™ (0.75 hours), ABP MOC Part 2 (0.75 hours), CME - Non-Physician (Attendance) (0.75 hours), Nursing CE (0.75 hours)

Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer. CME information and select publications here.

Longevity in a tough field is something you need to consider as well as the right mindsets that keep you there – be intentional about being gratefulLucas gives some advice in doing triage shifts and focusing on the good people you have the privilege to interact with and trying to be intentional about not focusing on the mean, angry patientIntentionality behind the things that improve your well-being are more important to prioritize than you might think Allow your family, significant other to help youFatherhood and dual income houses are more the norm now so both parents have to work toward raising children and workingLucas gives advice to the new ER physicianThe busier you are, the more stressed you are, the more you need to maintain hobbiesThe PA profession has done a good job of setting people up for success with having a good work and life balanceCommunity is super important to cultivate, the lone wolf diesIt can be easy to justify allowing relationships to wane when you are busy in medicine and education, but this cannot be put off foreverBreak the pattern of pushing off community in favor of careerSupport the showEverything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions. This is not medical advice. If you have personal health concerns, please seek professional care. Full show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition

The Latest Breakthroughs in LG-IR-NMIBC (2025) CME Available: auau.auanet.org/node/43689 After participating in this CME activity, participants will be able to: 1. Apply updated clinical evidence and treatment protocols for low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC) in appropriate patient cases to reduce recurrence rates and improve clinical outcomes. 2. Improve clinical decision-making related to risk stratification and surveillance strategies for low-grade, intermediate-risk NMIBC based on pathophysiology, epidemiology, and progression patterns. 3. Support evidence-based, patient-centered treatment selection options for low-grade, intermediate-risk NMIBC by comparing traditional intravesical therapies with emerging treatments. 4. Interpret the efficacy and safety profiles of new therapies to appropriately integrate new therapeutic options into clinical practice (upon regulatory approval). 5. Utilize new medications in the evolving treatment landscape following an evaluation of key clinical trial data from recent studies. 6. Assess the impact of treatment options on patient-reported outcomes, including quality of life and treatment burden, to guide shared decision-making and optimize care delivery. ACKNOWLEDGEMENTS Support provided by an independent educational grant from: UroGen Pharma, Inc.

The screw worm is closing in on Texas, threatening the nation's largest cattle herd and the beef market with it. Avian flu resurfaces, pork stays steady, and butter keeps sliding – but is beef facing its biggest challenge yet?BEEF: The new screw worm was found less than 70 miles from Texas, potentially impacting the beef industry. Prices are falling for many cuts, but ribeyes and tenderloins stay expensive. The real question – do we have a few more weeks of relief, or are we on the brink of something much bigger?POULTRY: Avian flu has returned, hitting 2.5 million egg layers in Wisconsin, with more turkey cases piling on. Chicken prices are falling, with wings, breasts, and tenders dropping in price. The question now is – will this market reset hold, or will avian flu spoil the party?GRAINS: Argentina tried a quick cash grab by suspending export duties on corn and soy, raking in billions in just two days before reinstating them. Here in the U.S., the markets barely blinked – corn ticked up to $4.15, with soy and wheat holding steady. Will global moves finally shake up these calm grain markets, or are we stuck in steady mode for a while longer?PORK: Bellies nudged up to $169, but don't be fooled – I still see more downside ahead for this market. Loins are steady, ribs are inching higher, and butts are showing some strength. The big question – are we about to see pork finally heat up, or will it stay the quiet value play against beef's chaos?DAIRY: The CME finally showed a flicker of life this week – barrel had its first uptick in a month, block slipped a bit lower, and butter keeps sliding. Is this the true bottom we've been waiting for, or will butter keep melting into the holiday baking season?Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

Michael Hein, MS, MD, MHCM, Associate Certified Coach (ACC), believes that when healthcare leaders don't fully understand complexity, it leads to burnout, turnover, and poor patient care—issues he considers preventable forms of human suffering. Healthcare is more complex than ever, and traditional top-down methods often exacerbate these challenges. Success today requires leaders who adapt, absorb uncertainty, and react quickly. For many, this means embracing new leadership mindsets. With over thirty years of experience in healthcare, Michael is Senior Vice President and an executive coach at MEDI Leadership, the top healthcare coaching firm in the US. Drawing from clinical and executive roles, he helps leaders make the mindset shifts needed for success in complexity.Previously, Michael was CEO of a nonmerger hospital network and Chief Medical Officer at Catholic Health Initiatives. He led transformations at the Veterans Health Administration and cofounded KPI Ninja, a healthcare data company.Michael holds degrees from the University of South Dakota, Harvard's T.H. Chan School of Public Health, and St. Cloud State University. He is a certified executive coach through the International Coaching Federation, trained at the Hudson Institute of Coaching. His experience bridges frontline care and strategic leadership, coaching leaders to drive sustainable change in complex organizations.His book, Shifting Toward Unorthodoxy: Ten Unconventional Mindsets that Help Healthcare Leaders Succeed in a Complex World, encourages a shift from outdated leadership mindsets to adaptive ones. A lifelong athlete, Michael enjoys cycling and swimming.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

With nearly one in ten newborns in the US requiring care in a Neonatal Intensive Care Unit, the importance of NICUs has never been more clear. On today's episode of Raise the Line, we're shining a light on the extraordinary world of NICUs with Lindsay Howard, a veteran nurse with over 17 years of experience caring for premature and critically ill infants. She currently works in a Level IV NICU at Children's Memorial Hermann Hospital in Houston, one of the most advanced neonatal units in the country. “We call ourselves ‘the ER of the neonate world' because we're never full. We have to make space no matter what comes in off the street, and at the biggest medical center in the world, we see all the things,” she explains. In this enlightening conversation with host Lindsey Smith, Howard describes how advances in medicine have made it possible to provide more types of care for younger and smaller babies, creating a need for NICU nurses to develop subspecialties. In her case, Howard is on a dedicated team that handles the placement and maintenance of all central line IVs, and has earned certifications in neonatal and pediatric chemotherapy and biotherapies. “We see babies that we may not have seen before being born with cancerous tumors who need chemotherapy to try and eliminate it, or just give them more time with their family.” This is a revealing look inside the workings of a top tier NICU where you'll learn about approaches to care that support healthy neurodevelopment, how clinical staff handle the emotional challenges of the job, and how her own experience as a mother with twins needing NICU care impacted her work.  Mentioned in this episode:Children's Memorial Hermann Hospital If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Today, Grid Down Comms Up takes the microphone again for another great episode of the Prepping Academy. We do a short after-action report on the Eastern Tennessee Homestead Alliance festival, revisit a few items as we approach the one-year anniversary of the historic disaster caused by Hurricane Helene, and talk about radio and communications interference. We look at the common types of manmade interference and what you can do to ensure you aren't the cause, because making lots of people look for you isn't very gray man. We also discuss what you may want to consider adding to your plans if you experience intentional interference during an emergency. We also listened to an example of interference during my time in Eastern Tennessee with GSM and a much more entertaining example of some amateur operators trolling someone who is causing intentional interference to keep him talking until they locate him. I'll see you on the next episode.  Support the showPlease give us 5 Stars! www.preppingacademy.com Daily deals for preppers, survivalists, off-gridders, homesteaders & everyday Americans. The best gear & supplies—posted in one place, every dayCheck out https://prepperfinds.com Contact us: https://preppingacademy.com/contact/ www.preppernet.net Amazon Store: https://amzn.to/3lheTRTwww.forrestgarvin.com

Welcome to Perimenopause WTF!, brought to you by ⁠Perry⁠—the #1 perimenopause app and safe space for connection, support, and new friendships during the menopause transition. You're not crazy, and you're not alone!  Download the free Perry App on ⁠Apple⁠ or ⁠Android⁠ and join our live expert talks, receive evidence-based education, connect with other women, and simplify your perimenopause journey.In today's episode, “When Hormones Trigger History: Understanding Trauma in Perimenopause.” Dr. Harita Raja and Dr. Heather Quaile get into the nitty gritty of trauma in perimenopause and menopause. They discuss topics like stress, triggers, hypervigilance, trauma informed care, the importance of sleep and so much more as they answer questions and scenarios sent in by the Perry community!

In this episode, Lillian Erdahl, MD, FACS, is joined by Jordan Rook, MD, from UCLA, and Lorraine Kelley-Quon, MD, FACS, from Children's Hospital Los Angeles and Keck School of Medicine of USC. They discuss Drs Rook and Kelley-Quon's recent article, “Expanding the Public Health Role of Pediatric Trauma Centers: Drug Screening for Adolescent Trauma Patients,” in which the authors found that biochemical drug screening for injured adolescents is decreasing at pediatric trauma centers, despite increasing national adolescent overdose deaths. Given high rates of substance use among injured adolescents, this is a missed opportunity to intervene on problematic substance use and prevent future adolescent overdose deaths.   Disclosure Information: Drs Rook, Kelley-Quon, and Erdahl have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

This Episode is sponsored by Ryze Health  Running your own practice shouldn't mean struggling with rising health insurance costs. That's why a physician designed Ryze Health Premium Insurance—exclusive coverage crafted for independent doctors, their teams, and families. Imagine lowering costs while gaining the freedom to focus fully on patients and the people who matter most. Discover how much you could save at ryzehealth.com and join the growing network of doctors choosing smarter coverage. Follow @RyzeHealth on Instagram and LinkedIn. __________________ How can physicians make the most of PIMD Con 2025 to transform their careers and achieve financial freedom?  In this episode of Bootstrap MD, Dr. Mike Woo-Ming, dives into practical strategies for attending PIMD Con, holding September 25–27, 2025, in Newport Beach, California. Founded by Dr. Peter Kim, this conference brings together 700+ physicians to explore real estate investing and entrepreneurship, offering CME credits, 30+ expert speakers, and tracks like Entrepreneurship Acceleration.  Mike shares tips on setting clear goals, researching speakers, effective networking, and avoiding common pitfalls like information overload or comparison traps. Whether you're a first-time attendee or a seasoned participant, this episode offers actionable advice to maximize your conference experience and build meaningful connections for long-term success. To register, visit: https://passiveincomemd.com/conferences/ Three Actionable Takeaways Set Clear, Specific Goals – Before attending PIMD Con, write down three specific objectives, such as learning rental property analysis or connecting with three key speakers. Review the conference website to align your goals with sessions and speakers to stay focused and intentional. Network Strategically with Value – Aim for 10–15 meaningful conversations with attendees and speakers. Ask unique questions like, “What brought you to PIMD Con?” or “What's your biggest business challenge?” and lead with value by sharing resources or connections without expecting immediate returns. Plan for Post-Conference Action – Block time after the conference to decompress and implement insights. Follow up with new contacts within 48 hours, using notes or photos to recall key details, and prioritize 1–2 focus areas to avoid overwhelm and maintain momentum. About the Show: Bootstrap MD is the ultimate podcast for physician entrepreneurs looking to escape traditional healthcare and control their financial futures. Hosted by Dr. Mike Woo-Ming, a successful physician, entrepreneur, and investor, the show delivers actionable insights on starting businesses, creating passive income, and navigating healthcare entrepreneurship. Featuring interviews with industry leaders, physicians, and experts in telemedicine and digital health, it's your guide to building a profitable, fulfilling career.  Tune in weekly at  http://bootstrapmd.com   About the Host: Dr. Mike Woo-Ming has over 20 years of experience as a physician entrepreneur. He's built and sold multiple seven-figure companies and now leads Executive Medical, a group of clinics specializing in age management and aesthetics. Through BootstrapMD, he mentors physicians in business, content creation, and autonomy. Let's Connect: www.https://www.bootstrapmd.com   Want to start a podcast? Check out the Doctor Podcast Network!  

Paroxysmal movement disorders refer to a group of highly heterogeneous disorders that present with attacks of involuntary movements without loss of consciousness. These disorders demonstrate considerable and ever-expanding genetic and clinical heterogeneity, so an accurate clinical diagnosis has key therapeutic implications. In this episode, Kait Nevel, MD, speaks with Abhimanyu Mahajan, MD, MHS, FAAN, author of the article “Paroxysmal Movement Disorders” in the Continuum® August 2025 Movement Disorders issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Mahajan is an assistant professor of neurology and rehabilitation medicine at the James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders at the University of Cincinnati in Cincinnati, Ohio. Additional Resources Read the article: Paroxysmal Movement Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Guest: @MahajanMD Full episode transcript available here Dr Jones: This is Doctor Lyell Jones, editor in chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kait Nevel. Today I'm interviewing doctor Abhi Mahajan about his article on diagnosis and management of paroxysmal movement disorders, which appears in the August 2025 Continuum issue on movement disorders. Abhi, welcome to the podcast and please introduce yourself to the audience. Dr Mahajan: Thank you, Kait. Thank you for inviting me. My name is Abhi Mahajan. I'm an assistant professor of neurology and rehabilitation medicine at the University of Cincinnati in Cincinnati, Ohio. I'm happy to be here. Dr Nevel: Wonderful. Well, I'm really excited to talk to you about your article today on this very interesting and unique set of movement disorders. So, before we get into your article a little bit more, I think just kind of the set the stage for the discussion so that we're all on the same page. Could you start us off with some definitions? What are paroxysmal movement disorders? And generally, how do we start to kind of categorize these in our minds? Dr Mahajan: So, the term paroxysmal movement disorders refers to a group of highly heterogeneous disorders. These may present with attacks of involuntary movements, commonly a combination of dystonia and chorea, or ataxia, or both. These movements are typically without loss of consciousness and may follow, may follow, so with or without known triggers. In terms of the classification, these have been classified in a number of ways. Classically, these have been classified based on the trigger. So, if the paroxysmal movement disorder follows activity, these are called kinesigenic, paroxysmal, kinesigenic dyskinesia. If they are not followed by activity, they're called non kinesigenic dyskinesia and then if they've followed prolonged activity or exercise they're called paroxysmal exercise induced dyskinesia. There's a separate but related group of protogynous movement disorders called episodic attacks here that can have their own triggers. Initially this was the classification that was said. Subsequent classifications have placed their focus on the ideology of these attacks that could be familiar or acquired and of course understanding of familiar or genetic causes of paroxysmal movement disorders keeps on expanding and so on and so forth. And more recently, response to pharmacotherapy and specific clinical features have also been introduced into the classification. Dr Nevel: Great, thank you for that. Can you share with us what you think is the most important takeaway from your article for the practicing neurologist? Dr Mahajan: Absolutely. I think it's important to recognize that everything that looks and sounds bizarre should not be dismissed as malingering. Such hyperkinetic and again in quotations, “bizarre movements”. They may appear functional to the untrained eye or the lazy eye. These movements can be diagnosed. Paroxysmal movement disorders can be diagnosed with a good clinical history and exam and may be treated with a lot of success with medications that are readily available and cheap. So, you can actually make a huge amount of difference to your patients' lives by practicing old-school neurology. Dr Nevel: That's great, thank you so much for that. I can imagine that scenario does come up where somebody is thought to have a functional neurological disorder but really has a proximal movement disorder. You mentioned that in your article, how it's important to distinguish between these two, how there can be similarities at times. Do you mind giving us a little bit more in terms of how do we differentiate between functional neurologic disorder and paroxysmal movement disorder? Dr Mahajan: So clinical differentiation of functional neurological disorder from paroxysmal movement disorders, of course it's really important as a management is completely different, but it can be quite challenging. There's certainly an overlap. So, there can be an overlap with presentation, with phenomenology. Paroxysmal nature is common to both of them. In addition, FND and PMD's may commonly share triggers, whether they are movement, physical exercise. Other triggers include emotional stimuli, even touch or auditory stimuli. What makes it even more challenging is that FND's may coexist with other neurological disorders, including paroxysmal movement disorders. However, there are certain specific phenom phenotypic differences that have been reported. So specific presentations, for example the paroxysms may look different. Each paroxysm may look different in functional neurological disorders, specific phenotypes like paroxysmal akinesia. So, these are long duration episodes with eyes closed. Certain kinds of paroxysmal hyperkinesia with ataxia and dystonia have been reported. Of course. More commonly we see PNES of paroxysmal nonepileptic spells or seizures that may be considered paroxysmal movement disorders but represent completely different etiology which is FND. Within the world of movement disorders, functional jerks may resemble propiospinal myoclonus which is a completely different entity. Overall, there are certain things that help separate functional movement disorders from paroxysmal movement disorders, such as an acute onset variable and inconsistent phenomenology. They can be suggestibility, distractibility, entrainment, the use of an EMG may show a B-potential (Bereitschaftspotential) preceding the movement in patients with FND. So, all of these cues are really helpful. Dr Nevel: Great, thanks. When you're seeing a patient who's reporting to these paroxysmal uncontrollable movements, what kind of features of their story really tips you off that this might be a proximal movement disorder? Dr Mahajan: Often these patients have been diagnosed with functional neurological disorders and they come to us. But for me, whenever the patient and or the family talk about episodic movements, I think about these. Honestly, we must be aware that there is a possibility that the movements that the patients are reporting that you may not see in clinic. Maybe there are obvious movement disorders. Specifically, there's certain clues that you should always ask for in the history, for example, ask for the age of onset, a description of movements. Patients typically have videos or families have videos. You may not be able to see them in clinic. The regularity of frequency of these movements, how long the attacks are, is there any family history of or not? On the basis of triggers, whether, as I mentioned before, do these follow exercise? Prolonged exercise? Or neither of the above? What is the presentation in between attacks, which I think is a very important clinical clue. Your examination may be limited to videos, but it's important not just to examine the video which represents the patient during an attack, but in between attacks. That is important. And of course, I suspect we'll get to the treatment, but the treatment can follow just this part, the history and physical exam. It may be refined with further testing, including genetic testing. Dr Nevel: Great. On the note of genetic testing, when you do suspect a diagnosis of paroxysmal movement disorder, what are some key points for the provider to be aware of about genetic testing? How do we go about that? I know that there are lots of different options for genetic testing and it gets complicated. What do you suggest? Dr Mahajan: Traditionally, things were a little bit easier, right, because we had a couple of genes that have been associated with the robust movement disorders. So, genetic testing included single gene testing, testing for PRRT2 followed by SLC2A. And if these were negative, you said, well, this is not a genetic ideology for paroxysmal movement disorders. Of course, with time that has changed. There's an increase in known genes and variants. There is increased genetic entropy. So, the same genetic mutation may present with many phenotypes and different genetic mutations may present with the similar phenotype. Single gene testing is not a high yield approach. Overall genetic investigations for paroxysmal movement disorders use next generation sequencing or whole exome sequence panels which allow for sequencing of multiple genes simultaneously. The reported diagnostic yield with let's say next generation sequencing is around 35 to 50 percent. Specific labs at centers have developed their own panels which may improve the yield of course. In children, microarray may be considered, especially the presentation includes epilepsy or intellectual disability because copy number variations may not be detected by a whole exome sequencing or next generation sequencing. Overall, I will tell you that I'm certainly not an expert in genetics, so whenever you're considering genetic testing, if possible, please utilize the expertise of a genetic counsellor. Families want to know, especially as an understanding of the molecular underpinnings and knowledge about associated mutations or variations keeps on expanding. We need to incorporate their expertise. A variant of unknown significance, which is quite a common result with genetic testing, may not be a variant of unknown significance next year may be reclassified as pathogenic. So, this is extremely important. Dr Nevel: Yeah. That's such a good point. Thank you. And you just mentioned that there are some genetic mutations that can lead to multiple different phenotypes. Seemingly similar phenotypes can be associated with various genetic mutations. What's our understanding of that? Do we have an understanding of that? Why there is this seeming disconnect at times between the specific genetic mutation and the phenotype? Dr Mahajan: That is a tough question to answer for all paroxysmal movement disorders because the answer may be specific to a specific mutation. I think a great example is the CACNA1A mutation. It is a common cause of episodic ataxia type 2. Depending on when the patient presents, you can have a whole gamut of clinical presentations. So, if the patient is 1 year old, the patient can present with epileptic encephalopathy. Two to 5 years, it can be benign paroxysmal torticollis of infancy. Five to 10 years, can present with learning difficulties with absence epilepsy and then of course later, greater than 10 years, with episodic ataxia (type) 2 hemiplegic migraine and then a presentation with progressive ataxia and hemiplegic migraines has also been reported. So not just episodic progressive form of ataxia has also been reported. I think overall these disorders are very rare. They are even more infrequently diagnosed than their prevalence. As such, the point that different genetic mutations present with different phenotypes, or the same genetic mutation I may present with different phenotypes could also represent this part. Understanding of the clinical presentation is really incomplete and forever growing. There's a new case report or case series every other month, which makes this a little bit challenging, but that's all the more reason for learning about them and for constant vigilance for patients who show up to our clinic. Dr Nevel: Yeah, absolutely. What is our current understanding of the associated pathophysiology of these conditions and the pathophysiology relating to the genetics? And then how does that relate to the treatment of these conditions? Dr Mahajan: So, a number of different disease mechanisms have been proposed. Traditionally, these were all thought to be ion channelopathies, but a number of different processes have been proposed now. So, depending on the genetic mutation that you talk about. So certain mutations can involve ion channels such as CACMA1A, ATP1A3. It can involve solute carriers, synaptic vesicle fusion, energy metabolism such as ECHS1, synthesis of neurotransmitters such as GCH1. So, there are multiple processes that may be involved. I think overall for the practicing clinician such as me, I think there is a greater need for us to understand the underlying genetics and associated phenotypes and the molecular mechanisms specifically because these can actually influence treatment decisions, right? So, you mentioned that specific genetic testing understanding of the underlying molecular mechanism can influence specific treatments. As an example, a patient presenting with proximal nocturnal dyskinesia with mutation in the ADCY5 gene may respond beautifully to caffeine. Other examples if you have SLC2A1, so gluc-1 (glucose transporter type 1) mutation, a ketogenic diet may work really well. If you have PDHA1 mutation that may respond to thiamine and so on and so forth. There are certain patients where paroxysmal movement disorders are highly disabling and you may consider deep brain stimulation. That's another reason why it may be important to understand genetic mutations because there is literature on response to DBS with certain mutations versus others. Helps like counselling for patients and families, and of course introduces time, effort, and money spent in additional testing. Dr Nevel: Other than genetic testing, what other diagnostic work up do you consider when you're evaluating patients with a suspected paroxysmal movement disorder? Are there specific things in the history or on exam that would prompt you to do certain testing to look for perhaps other things in your differential when you're first evaluating a patient? Dr Mahajan: In this article, I provide a flow chart that helps me assess these patients as well. I think overall the history taking and neurological exam outside of these paroxysms is really important. So, the clinical exam in between these episodic events, for example, for history, specific examples include, well, when do these paroxysms happen? Do they happen or are they precipitated with meals that might indicate that there's something to do with glucose metabolism? Do they follow exercise? So, a specific example is in Moyamoya disease, they can be limb shaking that follows exercise. So, which gives you a clue to what the etiology could be. Of course, family history is important, but again, talking about the exam in between episodes, you know, this is actually a great point because out– we've talked about genetics, we've talked about idiopathic paroxysmal movement disorders, –but a number of these disorders are because of acquired causes. Well, of course it's important because acquired causes such as autoimmune causes, so multiple sclerosis, ADEM, lupus, LGI1, all of these NMDAR, I mentioned Moyamoya disease and metabolic causes. Of course, you can consider FND as under-acquired as well. But all of these causes have very different treatments and they have very different prognosis. So, I think it's extremely important for us to look into the history with a fine comb and then examine these patients in between these episodes and keep our mind open about acquired causes as well. Dr Nevel: When you evaluate these patients, are you routinely ordering vascular imaging and autoimmune kind of serologies and things like that to evaluate for these other acquired causes or it does it really just depend on the clinical presentation of the patient? Dr Mahajan: It mostly depends on the clinical presentation. I mean, if the exam is let's say completely normal, there are no other risk factors in a thirty year old, then you know, with a normal exam, normal history, no other risk factors. I may not order an MRI of the brain. But if the patient is 55 or 60 (years) with vascular risk factors, then you have to be mindful that this could be a TIA. If the patient has let's say in the 30s and in between these episodes too has basically has a sequel of these paroxysms, then you may want to consider autoimmune. I think the understanding of paraneoplastic, even autoimmune disorders, is expanding as well. So, you know the pattern matters. So, if all of this is subacute started a few months ago, then I have a low threshold for ordering testing for autoimmune and paraneoplastic ideology is simply because it makes such a huge difference in terms of how you approach the treatment and the long-term prognosis. Dr Nevel: Yeah, absolutely. What do you find most challenging about the management of patients with paroxysmal movement disorders? And then also what is most rewarding? Dr Mahajan: I think the answer to both those questions is, is the same. The first thing is there's so much advancement in what we know and how we understand these disorders so regularly that it's really hard to keep on track. Even for this article, it took me a few months to write this article, and between the time and I started and when I ended, there were new papers to include new case reports, case series, right? So, these are rare disorders. So most of our understanding for these disorders comes from case reports and case series, and it's in a constant state of advancement. I think that is the most challenging part, but it's also the most interesting part as well. I think the challenging and interesting part is the heterogeneity of presentation as well. These can involve just one part of your body, your entire body can present with paroxysmal events, with multiple different phenomenologies and they might change over time. So overall, it's highly rewarding to diagnose such patients in clinic. As I said before, you can make a sizeable difference with the medication which is usually inexpensive, which is obviously a great point to mention these days in our health system. But with anti-seizure drugs, you can put the right diagnosis, you can make a huge difference. I just wanted to make a point that this is not minimizing in any way the validity or the importance of diagnosing patients with functional neurological disorders correctly. Both of them are as organic. The importance is the treatment is completely different. So, if you're diagnosing somebody with FND and they do have FND and they get cognitive behavioral therapy and they get better, that's fantastic. But if somebody has paroxysmal movement disorders and they undergo cognitive behavioral therapy and they're not doing well, that doesn't help anybody. Dr Nevel: One hundred percent. As providers, obviously we all want to help our patients and having the correct diagnosis, you know, is the first step. What is most interesting to you about paroxysmal movement disorders? Dr Mahajan: So outside of the above, there are some unanswered questions that I find very interesting. Specifically, the overlap with epilepsy is very interesting, including shared genes, the episodic nature, presence of triggers, therapeutic response to anti-seizure drugs. All of this I think deserves further study. In the clinic, you may find that epilepsy and prognosis for movement disorders may occur in the same individual or in a family. Episodic ataxia has been associated with seizures. Traditionally this dichotomy of an ictal focus. If it's cortical then it's epilepsy, if it's subcortical then it's prognosis for movement disorders. This is thought to be overly simplistic. There can be co-occurrence of seizures and paroxysmal movement disorders in the same patient and that has led to this continuum between these two that has been proposed. This is something that needs to be looked into in more detail. Our colleagues in Epilepsy may scoff this, but there's concept of basal ganglia epilepsy manifesting as paroxysmal movement disorders was proposed in the past. And there was this case report that was published out of Italy where there was ictal discharge from the supplementary sensory motor cortex with a concomitant discharge from the ipsilateral coordinate nucleus in a patient with paroxysmal kinesigenic cardioarthidosis. So again, you know, basal ganglia epilepsy, no matter what you call it, the idea is that there is a clear overlap between these two conditions. And I think that is fascinating. Dr Nevel: Really interesting stuff. Well, thank you so much for chatting with me today. Dr Mahajan: Thank you, Kait. And thank you to the Continuum for inviting me to write this article and for this chance to speak about it. I'm excited about how it turned out, and I hope readers enjoy it as well. Dr Nevel: Today again, I've been interviewing doctor Abhi Mahajan about his article on diagnosis and management of paroxysmal movement disorders, which appears in the August 2025 Continuum issue on movement disorders. I encourage all of our listeners to be sure to check out the Continuum Audio episodes from this and other issues. As always, please read the Continuum articles where you can find a lot more information than what we were able to cover in our discussion today. And thank you for our listeners for joining today. And thank you, Abhi, so much for sharing your knowledge with us today. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this CME episode, Dr. Andy Cutler speaks with Dr. Manpreet Singh, the Robert H. Putnam Endowed Chair in Bipolar Research and Treatment at UC Davis, about the challenges of diagnosing and treating pediatric bipolar disorder. Dr. Singh shares evidence-based strategies for treatment, management of bipolar depression and medication side effects, and best practices for long-term care and transitioning youth into adult services.  NEI Members can earn CME/CE by participating in this activity here: https://nei.global/e264-cme Never miss an episode!

The Latest Breakthroughs in mHSPC CME Available: https://auau.auanet.org/node/43825 After participating in this CME activity, participants will be able to: 1.Evaluate the concept of personalized therapy and its importance in the treatment of de novo mHSPC. 2.Implement current clinical guidelines for biomarker testing in mHSPC. 3.Explain the role of the PI3K/AKT pathway in prostate cancer biology. 4.Explore collaborations between urologists, oncologists, radiologists, and other healthcare professionals in managing de novo mHSPC. 5.Employ strategies to manage and mitigate common adverse events associated with AKT inhibitors and other therapies used in mHSPC. Acknowledgements: AstraZeneca Bayer HealthCare Pharmaceuticals Inc.

 Can physicians break the cycle of procrastination and reclaim their personal lives? Dr. Bradley Block and Dr. Russell Ramsay dive into practical approaches for managing time, tackling dreaded tasks like charting and difficult patient calls, and addressing perfectionism. Drawing from his expertise in adult ADHD, Dr. Ramsay discusses behavioral scripts, implementation intentions, and reframing tasks to build momentum and reduce avoidance. While emphasizing that these skills benefit everyone, he highlights the role of social capital, small actions for big gains, and tools like talk-to-text for efficiency. Tune in for insights on current challenges, actionable strategies, and how to stay motivated—part one of a two-part series.Three Actionable Takeaway: Behavioral Scripts for Task Initiation – Break down challenging tasks, like difficult patient phone calls, into clear roles and minimal actions (e.g., communicate key information). Dr. Ramsay explains this reduces avoidance by focusing on fulfilling your professional duty, similar to starting gym routines with small steps like wearing gym clothes.Combat Perfectionism with Good Enough Standards – Identify where perfectionism slows you down (e.g., over-editing notes or emails) and reframe to "fully competent" outcomes. Dr. Ramsay suggests using timers, word limits, or talk-to-text to draft quickly, and evaluating trade-offs like lost family time to incentivize efficiency.Build Momentum Through Small Actions – Use implementation intentions ("If X, then Y") and "touch the task" techniques to start admin work or self-care. Dr. Ramsay notes that small steps, like opening a chart or comparing colleagues' efficient notes, create inertia and help shift from "have to" to intentional productivity.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Russell Ramsay is a psychologist specializing in the assessment and psychosocial treatment of adult ADHD. With international lectures and over six books, including CBT for Adult ADHD and The Adult ADHD Toolkit, he advises on behavioral strategies for efficiency and well-being. Formerly at the University of Pennsylvania Perelman School of Medicine, he focuses on helping professionals, including physicians, manage procrastination and perfectionism. LinkedIn: https://www.linkedin.com/in/russell-ramsay-a8bbb310Website: https://www.cbt4adhd.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Have you ever wondered how executive recruiters work? Or why some recruiters seem more invested in your job search than others?  In this episode of The Career Rx we'll discuss: The different types of recruiter models - retained, contingent, and in-house How recruiters can help you navigate the job market and land your dream role Tips on how to negotiate your salary and benefits effectively  In this episode, we dive into the world of retained executive search with Brian Evans, a seasoned recruiter from Discovery Search Partners. He shares insights into the recruiting process, how to work effectively with recruiters, and what you can expect from a retained search firm.  In this Episode:  Learn about internal vs. external talent acquisition, including retained and contingency search, recruitment agency types, and fees.  Understand how recruiters are compensated, and whether that impacts how they work with candidates – and candidate offers   How recruiters really use LinkedIn, and how to optimize your profile to get noticed Find out how recruiters can provide company insights, help candidates prep for interviews, and more   Links and Resources:  Industry Insider - 12 hours of CME, learn exactly how to land a rewarding nonclinical career without a new degree, special connections, prior experience, or a pay cut    Support the show

Featuring an interview with Prof Peter Schmid, including the following topics: Response to immunotherapy in breast cancer subtypes (0:00) Tolerability of TROP2 antibody-drug conjugates (ADCs) for metastatic breast cancer (mBC) (3:51) Approaches to therapy for patients with HR-negative HER2-low and HER2-ultralow mBC (13:03) ADC structure and treatment-related adverse events (19:02) Available data from the Phase III ASCENT-04 trial evaluating sacituzumab govitecan with pembrolizumab as first-line therapy for patients with PD-L1-positive advanced triple-negative breast cancer (23:06) Novel ADCs and bispecific antibodies under investigation for mBC (28:30) Comparing datopotamab deruxtecan and sacituzumab govitecan for HR-positive disease (33:01) Clinical investigator perspectives on the Phase III DESTINY-Breast09 trial evaluating first-line trastuzumab deruxtecan with or without pertuzumab versus THP (docetaxel/rastuzumab/pertuzumab) for HER2-positive mBC (35:06) CME information and select publications

Send us a textWhat if your most complex visits were being paid as basic ones—and no one on your team even noticed?That's not a hypothetical. It's happening right now.Today we're talking about something that could be quietly draining your revenue, hurting your bottom line, and going completely unnoticed by your billing team: automatic downcoding of high-level E/M visits. This is a new policy from Cigna, and they're not alone. Other major payers—including UHC—are doing the same thing. And they're doing it in a way that makes it difficult to detect, hard to fight, and shockingly easy to miss.If you're a physician, a practice administrator, a billing leader—anyone responsible for the financial health of your practice—this episode is critical listening. Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Find it here: https://healtheps.com/physicians-edge-mastering-business-finance-in-your-medical-practice/ Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer. CME information and select publications here.

What is humanism? What role can the Black church play in improving the maternal health crisis in America?In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, anti-racism educator, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Dr. Wylin D. Wilson, author and Assistant Professor of Theological Ethics at Duke Divinity School. They explore the benefits of long-term engagement with Black communities for improving healthcare outcomes for all, emphasizing the importance of lifting up people both within and beyond your own community.Wylin D. Wilson is Assistant Professor of Theological Ethics at Duke Divinity School where she teaches Womanist Bioethics within the Theology Medicine and Culture program. She is the author of Economic Ethics and the Black Church and Womanist Bioethics: Social Justice,Spirituality, and Black Women's Health.LINKShttps://wylindwilson.com**You can learn more about Dr. Wener and her online anti-racism, meditation and tapping courses at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism.If you're a healthcare worker looking for a CME-accredited course, check out Conscious Anti-Racism: Tools for Self-Discovery, Accountability, and Meaningful Change in Healthcare at www.theresttechnique.com/courses/conscious-anti-racism-healthcareFollow her on:Instagram at jillwenerMDLinkedIn at jillwenermd

In this episode of Bowel Sounds, hosts Dr. Peter Lu and Dr. Jason Silverman talk to Dr. Amber Hildreth, pediatric gastroenterologist and transplant hepatologist at Rady Children's Hospital and Assistant Professor at the University of California San Diego. She is also a clinician scientist at the Rady Children's Institute for Genomic Medicine. We discuss how genetic testing is transforming the way we care for children with rare GI and liver diseases.Learning objectivesRecognize key differences between various types of genetic testing.Discuss several applications of genetic testing in care for children with GI disorders.Understand the role of the genetic counselor in integrating genetic testing into GI practice.Support the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Featuring a slide presentation and related discussion from Prof Peter Schmid, including the following topics: Evolution of the therapeutic landscape for metastatic triple-negative breast cancer; age of immunotherapy (0:00) Case: A woman in her early 40s with no actionable mutations (7:29) Evolution of antibody-drug conjugates (ADCs) in the management of metastatic breast cancer (11:13) TROP2-directed ADCs (15:22) Case: A woman in her early 50s with PD-L1-negative, HR-negative, HER2-low de novo metastatic breast cancer (20:21) Novel strategies utilizing approved and investigational ADCs (23:28) Case: A woman in her early 60s with loss of HER2 expression on disease progression (31:39) ADCs in combination with immunotherapy (32:51) CME information and select publications

Dr Jonathan Strosberg from Moffitt Cancer Center in Tampa, Florida, discusses recent updates on available and novel treatment strategies for extrapulmonary neuroendocrine carcinoma. CME information and select publications here.

Furman McDonald, MD, MPH, President a CEO of the American Board of Internal Medicine (ABIM), joins ACCME President and CEO, Graham McMahon, MD, MMSc, to reflect on 10 years of collaboration between ACCME and ABIM. Listen in as they articulate the distinct and complementary roles of certification and accredited CME, and make the case for rigorous, trusted systems of physician accountability and lifelong learning.

Featuring an interview with Dr Jonathan Strosberg, including the following topics: Overview of extrapulmonary neuroendocrine carcinoma (NEC) (0:00) Treatment strategies for extrapulmonary NEC (10:26) Targeting DLL3 in extrapulmonary NEC (18:49) Early clinical data with obrixtamig for extrapulmonary NEC (21:56) Additional investigational agents for extrapulmonary NEC (25:44) Case: A woman in her mid 50s with poorly differentiated metastatic NEC of unknown primary (27:20) Case: A man in his early 60s with poorly differentiated metastatic esophageal NEC (32:30) Clinical management of well-differentiated NEC (36:58) CME information and select publications  

In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the September 2025 Emergency Medicine Practice article, Emergency Department Management of Patients With Status Epilepticus Topic IntroductionFocus: Status Epilepticus in AdultsReference to recent pediatric episodeArticle authors: Dr. Marquez, Dr. Kaur, Dr. LayWhy Status Epilepticus MattersTeaching value and clinical challengeTeam-based care and multidisciplinary involvementGuidelines and EvidenceReview of major guidelines (International League Against Epilepsy, Neurocritical Care Society, American Epilepsy Society)Key trials: EcLiPSE, ConSEPT, ESETTUpdated definition of status epilepticusClassification and DiagnosisConvulsive vs. non-convulsive statusImportance of repeated neurologic examsDiagnostic challenges and mimics (e.g., syncope, psychogenic seizures)Etiology and WorkupAcute vs. non-acute causesCommon triggers: medication noncompliance, metabolic issues, infections, traumaImportance of sleep patterns and ammonia levelsThe NORSE acronym (new onset refractory status epilepticus)Prehospital and ED ManagementAirway, breathing, circulation prioritiesEarly pharmacologic intervention (IM midazolam preferred in prehospital)Gathering history and medication informationPositioning and airway protectionDiagnosticsLaboratory workup: glucose, CBC, metabolic panel, drug levels, pregnancy testImaging: non-contrast CT, MRI, ultrasound, lumbar punctureEEG: spot vs. continuous monitoringTreatment ApproachFirst-line: Benzodiazepines (lorazepam, midazolam)Second-line: Levetiracetam, valproate, fosphenytoin, phenobarbital, lacosamideThird-line: Continuous infusions (midazolam, propofol, pentobarbital, thiopental, ketamine)Dosing pearls and importance of rapid escalationSpecial PopulationsPregnancy (eclampsia: magnesium as first-line)Substance-induced status epilepticus (e.g., isoniazid toxicity and pyridoxine)Brief mention of pediatric management and the PD stat appRisk Management PitfallsNon-convulsive status is common and easily missedImportance of weight-based dosingNeed for formal EEG in ambiguous casesDon't assume non-adherence is the only cause in known epilepticsAlways consider higher level of care for status patientsClinical PathwayStepwise approach to medication and escalationEmphasis on having a pathway/checklist for these high-stress casesConclusionRecap of key pointsThanks to authors and listenersReminder to visit ebmedicine.net for CME and resourcesEmergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

ER physician for 15 yearsHe talks about this path into med school and emergency medicine as his first choiceHe likes the challenge, lack of predictability and wide scope of problems we must solve. We have the honor to accept patients when no one else willLucas talks about how the term emergency medicine is almost becoming antiquated when we are doing acute, undifferentiated careSome of the care is emergencies, but not all. And that's probably for the best so we don't get burned outHe talks about burnout and how we should focus on how to manage it when it happens as opposed to how to prevent it all the timeYou need to accept that burnout will happen, so you don't have an expectation mismatchBeing aware of your own burnout is key to correcting itOptimizing the other things in your life outside of work like exercise, nutrition, community is keyBe intentional about focusing on the enriching case, appreciative patient, positive conversation you have throughout the day. If you look for the positive you will find it and then do whatever you need to do to get it in your long-term memoryLucas talks about gratitude and how this requires intentionality as wellWe talk about how much to share with spouses We talk about the role of the clinician in the ED and how we have a lot of things to manage that other staff may not seeWe talk about how to manage our limited resourcesSupport the showEverything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions. This is not medical advice. If you have personal health concerns, please seek professional care. Full show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition

Dr Jonathan Strosberg from Moffitt Cancer Center in Tampa, Florida, discusses recent updates on available and novel treatment strategies for extrapulmonary neuroendocrine carcinoma. CME information and select publications here.

Featuring a slide presentation and related discussion from Dr Jonathan Strosberg, including the following topics: Overview of the classification, grading and incidence of neuroendocrine carcinoma (NEC) (0:00) Overview of mutational profile, biomarker assessments and prognosis of NEC (3:45) Current treatment paradigm for extrapulmonary NEC (8:59) DLL3 as an emerging target biomarker in extrapulmonary NEC (17:46) Novel therapeutic agents under investigation for extrapulmonary NEC (23:05) CME information and select publications

Crypto News: First U.S. XRP ETF Launches Sept. 18, CME to List Options on XRP Futures Oct. 13. SEC Makes Spot Crypto ETF Listing Process Easier, Approves Grayscale's Large-Cap Crypto Fund.Show Sponsor -

Welcome back to our quarterly Market Cap Game Show! Two past champions—Andy Cross and Yasser El-Shimy—take the stage to test their market-cap mettle (and yours) across ten public companies, vying for a spot in the 2026 March Market Cap Madness World Championships. From tech titans and international hotel brands to down home Texas fare and online car shopping, the matchups run from familiar to delightfully unexpected—plus plenty of banter. Can you outscore Andy, Yasser, or both? Play along, challenge your market cap intuition, and discover the surprising values of companies you know and love (and maybe a few you've never heard of!). Companies mentioned: ASR, CARG, CEG, CME, GOOG, LKQ, MAR, NXP, PGR, TXRH Sign up for The Motley Fool's Breakfast News here: ⁠www.fool.com/breakfastnews⁠ Order David's Rule Breaker Investing book here: ⁠https://www.amazon.com/gp/product/1804091219/ Host: David Gardner Guests: Andy Cross, Yasser El-Shimy Producers: Bart Shannon, Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Hey listeners! Got plans for October 10th and 11th? Well, clear your calendars, because the FACTS About Fertility Virtual Conference is coming in hot and you won't want to miss it. Listen in today to Dr. Marguerite Duane and all the incredible work she is doing with FACTS, but also she is now the Director of the first ever Fertility Awareness Based Medical program in a medical school, Duquesne University! We're talking TWO days of inspiring talks, real connection, and expert insight—all from the comfort of your favorite sweatpants.

Grow your management tools for opioid withdrawal in the hospital. Investigate how to decide between methadone and buprenorphine, additional medications to manage symptoms and how and when to use short-acting opioids for management of withdrawal. We're joined by Ashish Thakrar, MD at the University of Pennsylvania.  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME! Show Segments Intro, disclaimer, guest bio Guest one-liner Case from Kashlak; Definitions Symptoms of opioid withdrawal Medications for the management of opioid withdrawal Buprenorphine precipitated withdrawal Starting Buprenorphine: Experiences and Strategies  Titrating Methadone: Dosage and Adjuncts Adjunctive short-acting opioids Emerging Trends in Drug Supply: Xylazine and Medetomidine Outro  Credits Producer, Show Notes: Zina Huxley-Reicher Infographics: Zina Huxley-Reicher MD and Zoya Surani Hosts: Carolyn Chan, MD MHS, Zina Huxley-Reicher MD, Shawn Cohen, MD Reviewer: Payel Jhoom Roy, MD, MSc Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Ashish Thakrar, MD MHSP Sponsor: Mint Mobile  Shop plans at MINTMOBILE.com/CURB Sponsor: Freed Use code: CURB50 to get $50 off your first month when you subscribe! Sponsor: FIGS  We've teamed up with FIGS, and now Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.

Dan Nathan is joined by Danny Moses and Terry Duffy, Chairman and CEO of CME Group, to discuss their partnership and market evolution. They talk about the growth in retail trading, the impact of technological advancements, and CME's new products like futures, event contracts, and binary contracts designed for retail investors. The discussion also covers the significance of risk management tools such as stop-losses, the recent rise in open positions in equity and interest rates at CME, and the broader implications of high national debt and technology disruption on the markets. They delve into the importance of timing in listing products, using Bitcoin's listing in 2017 as an example, and touch on the interconnectedness of global financial stability and market structure. —FOLLOW USYouTube: @RiskReversalMediaInstagram: @riskreversalmediaTwitter: @RiskReversalLinkedIn: RiskReversal Media